Company intelligence / Profile preview

M Bio Technology Inc.

Ownership: Private
Development stage: Commercial

Overview

M Bio Technology has developed proprietary diagnostic platforms and is advancing first-in-class chemically synthesized glycolipid-antigen vaccines targeting mycoplasma-related diseases. Their ELISA-based diagnostics are already being used clinically in Japan. They are pursuing clinical trial programs for vaccine candidates addressing neurological autoimmune conditions like CIDP and GBS, as well as exploring applications for post-COVID syndromes. No published late-stage clinical results yet.

Therapeutic areas: PulmonologyImmunologyRheumatologyNeurologyNephrologyInfectious Diseases
Modalities: Vaccines (chemically synthesized glycolipid-antigen vaccines)Monoclonal antibodiesDiagnostic assays (ELISA, MID Prism®)
Industry: Biotech

Drug pipeline

2 assets

MID Vaccine

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

SRL Inc. – major Japanese testing company partner for diagnostic commercializationEuropean partners – mid-scale production of ELISA systems/vaccine developmentYamaguchi University Department of Medical Neurology – joint research on serum studies/CIDP

Beyond the preview

Go deeper on M Bio Technology Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M Bio Technology Inc..

Explore the full profile